Neovii Pharmaceuticals

Neovii Pharmaceuticals is owned by Neopharm Group. Neopharm Group has a direct presence in 2 countries.

They are in:

• Pharmaceuticals67%
• Healthcare33%

View the org chart displaying its 3 main executives

Most searched biographies at Neovii Pharmaceuticals

• Christian Loss, Chief Executive Officer and General Manager
• Sebastian Hofmann, Vice President, Managing Director & Country Hea...
• Alfred Doucette, Chief Financial Officer

Create your alert
to follow the executive moves at Neovii Pharmaceuticals.

Neopharm Group has 1,867 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Neovii Pharmaceuticals

• News & Events

Social media about Neovii Pharmaceuticals

• Neovii Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Neovii Pharmaceuticals on LinkedIn, Twitter & YouTube

Contact by email its executives including Christian Loss

Call Neovii Pharmaceuticals at +49 89...

View the org chart

Register to receive your alert

Report an error